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Dear Sirs,
The striking paradox of pure autosomal dominant heredi-
tary spastic paraplegia (AD HSP), in contrast to capsular
stroke or primary lateral sclerosis, for example, is that
despite extensive corticospinal tract (CST) degeneration
and prominent lower limb spasticity, leg weakness is not a
prominent early feature of the disease. Therefore, other
descending motor pathways presumably compensate for
CST degeneration, though, until the recent article by
Nonnekes et al. [1] in the Journal of Neurology, this
assumption had remained unproven. Using startling
acoustic stimuli (SAS), they showed that the reticulospinal
tract (RST) is not only functioning in patients with HSP,
but that it compensates for lower limb deficits of postural
control caused by CST degeneration.
In most patients with pure AD HSP, electrophysiologi-
cal evidence of CST disease is limited to the lumbosacral
cord [2]. However, some AD HSP genotypes (e.g., SPG4)
are associated with a more severe phenotype and have
motor-evoked potential (MEP) abnormalities in the upper
limbs [3–5], consistent with post-mortem evidence of CST
degeneration at all levels, from the medulla to the lumbo-
sacral cord [6].
We tested MEPs (see Supplementary Methods) in two
patients (father and son) with SPG31 AD HSP (REEP1
exon 5 c.337C [ T/p.Arg113X [7]). In patient 2 (age 42;
disease duration 37 years) MEPs were ‘typical’ of pure AD
HSP [8], with prolonged central motor conduction times
(CMCTs) in the lower limbs (CMCT 22.2 ms) and normal
CMCTs in the upper limbs. However, in patient 1 (age 68;
disease duration 64 years) CMCTs were significantly pro-
longed in the upper limbs (Fig. 1).
Given the absence of clinical upper limb weakness in
patient 1, we measured EMG onset latencies in a Start-
React paradigm to see whether the RST might be com-
pensating for the CST deficit in the upper limbs [9–11]
(Supplementary Methods), as illustrated in Fig. 2a.
Experiments had the relevant institutional ethical approval
and complied with the Declaration of Helsinki, and were
performed in both patients and 11 controls, aged
56–82 years. Traditionally, the effects of SAS on the visual
reaction time (VRT), and the visual start-react time
(VSRT), are normalized, thus:
DVRT %ð Þ ¼ VRT  VSRTð Þ
VRT
 100: ð1Þ
The normal DVRT is *50 % [9], and a DVRT of less
than 50 % is indicative of disease affecting the RST.
However, because we were interested in measuring any
change in the gain of the RST output, accessed via auditory
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pathways, we have used a ratio that incorporates the
auditory reaction time (ART) following a low-intensity
sound, as follows:
DTSR=DTAR ¼ ðVRT  VSRTÞðVRT  ART) ð2Þ
where DTSR is the shortening effect of a SAS on the visual
reaction time and DTAR measures the shortening of reac-
tion time provided by a non-startling auditory stimulus,
which presumably does not activate RST pathways. The
results of this analysis are shown in Fig. 2c, d. Patient 2,
who had no evidence of cervical CST disease, had normal
DTSR/DTAR ratios. However, patient 1, who had MEP
evidence of cervical CST disease, had significantly
increased ratios, but only when measured from biceps
brachii EMG, despite normal ARTs and VRTs (Supple-
mentary Results/Fig. 2). This result supports the notion
that the RST mitigates the effects of disease within the
cervical CST. The RST appears to compensate by
increasing its output gain by a factor of around 1.5.
Although the RST does project to both proximal and distal
upper limb muscles [12], the effects of SAS are only seen
in distal muscles in some tasks [13], possibly explaining
why we detected differences only in the biceps muscle.
These observations suggest that therapeutic interventions
aimed at increasing the gain of RST outputs could
improve recovery from neurological disorders character-
ized by CST dysfunction.
Fig. 1 Examples of rectified motor-evoked potentials (MEPs)
obtained from a 68-year-old patient with SPG31/REEP1 HSP (black)
and an age-matched control (grey), aligned to the stimulus. a Upper
limb MEPs recorded from right first dorsal interosseous (R FDI) and
extensor digitorum (R EDC) muscles and evoked with a single
transcranial magnetic stimulus (indicated by an arrow) at 70 % of
maximum stimulator output (MSO), equivalent to 1.9 times the active
motor threshold (AMT; for details see Supplementary Methods). Each
trace is an average of 20 individual MEPs. Voltage calibration bars
apply to both patient and control MEPs. b Lower limb MEPs recorded
from right extensor digitorum brevis (R EDB) and tibialis anterior (R
TA) muscles using a stimulus strength of 1.6x AMT (70 % MSO).
c Right upper limb (FDI) central motor conduction time (CMCT).
d Right lower limb (EDB) CMCT. In c and d, peripheral motor
conduction times were subtracted from the FDI and EDB MEPs
shown in a and b, revealing the CMCT and the result plotted on a
longer time base. Solid vertical lines show the mean CMCT within
the normal population (aligned to the start), and the grey boxes
between vertical dashed lines extend two standard deviations above
and below the mean [14]. Arrow heads indicate MEP onset
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Fig. 2 a Example of normal raw rectified EMG data recorded from
right biceps brachii in a 61-year-old male control subject performing
the Start-React task. The EMG burst from which the VRT was
measured is plotted in black, that from which the ART was derived is
plotted in grey and the VSRT response is plotted in red. b, c Mean
DTSR/DTAR ratios calculated from EMG onset latencies measured in
Start-React experiments are plotted. b Right first dorsal interosseous
(R FDI) and c right biceps brachii (R BB). Error bars are standard
error of the mean. Note that in patient 1, the R BB ratio is
significantly increased (one-sample t test; p \ 0.01)
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